A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Elevance Health, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 31,251 shares of ELV stock, worth $11.9 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
31,251
Previous 32,467 3.75%
Holding current value
$11.9 Million
Previous $17.6 Million 7.62%
% of portfolio
0.06%
Previous 0.07%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$500.12 - $562.29 $608,145 - $683,744
-1,216 Reduced 3.75%
31,251 $16.3 Million
Q2 2024

Jul 26, 2024

BUY
$497.49 - $547.8 $2.27 Million - $2.5 Million
4,566 Added 16.37%
32,467 $17.6 Million
Q1 2024

Apr 24, 2024

BUY
$464.61 - $519.96 $1.98 Million - $2.22 Million
4,271 Added 18.07%
27,901 $14.5 Million
Q4 2023

Feb 09, 2024

SELL
$433.51 - $488.06 $345,940 - $389,471
-798 Reduced 3.27%
23,630 $11.1 Million
Q3 2023

Oct 24, 2023

BUY
$414.13 - $475.93 $940,075 - $1.08 Million
2,270 Added 10.24%
24,428 $10.6 Million
Q2 2023

Jul 13, 2023

BUY
$436.33 - $496.2 $2.71 Million - $3.08 Million
6,216 Added 38.99%
22,158 $9.85 Million
Q1 2023

May 11, 2023

SELL
$446.3 - $502.2 $968,024 - $1.09 Million
-2,169 Reduced 11.98%
15,942 $7.33 Million
Q4 2022

Feb 08, 2023

SELL
$465.23 - $546.77 $813,687 - $956,300
-1,749 Reduced 8.81%
18,111 $9.29 Million
Q3 2022

Oct 17, 2022

BUY
$445.98 - $507.0 $367,487 - $417,768
824 Added 4.33%
19,860 $0
Q2 2022

Jul 13, 2022

SELL
$444.32 - $529.84 $106,636 - $127,161
-240 Reduced 1.25%
19,036 $9.19 Million
Q1 2022

May 12, 2022

BUY
$428.44 - $502.48 $115,250 - $135,167
269 Added 1.42%
19,276 $9.47 Million
Q4 2021

Feb 03, 2022

BUY
$370.08 - $467.67 $564,001 - $712,729
1,524 Added 8.72%
19,007 $8.81 Million
Q3 2021

Nov 02, 2021

SELL
$357.51 - $398.13 $488,716 - $544,243
-1,367 Reduced 7.25%
17,483 $6.52 Million
Q2 2021

Aug 10, 2021

BUY
$352.19 - $401.9 $321,549 - $366,934
913 Added 5.09%
18,850 $7.2 Million
Q1 2021

May 07, 2021

SELL
$287.7 - $371.31 $204,267 - $263,630
-710 Reduced 3.81%
17,937 $6.44 Million
Q4 2020

Feb 04, 2021

SELL
$270.17 - $333.15 $1.65 Million - $2.04 Million
-6,123 Reduced 24.72%
18,647 $5.99 Million
Q3 2020

Oct 29, 2020

BUY
$245.73 - $284.63 $827,864 - $958,918
3,369 Added 15.74%
24,770 $6.65 Million
Q2 2020

Jul 27, 2020

BUY
$203.3 - $300.59 $152,678 - $225,743
751 Added 3.64%
21,401 $5.63 Million
Q1 2020

May 08, 2020

SELL
$174.68 - $307.74 $2.58 Million - $4.54 Million
-14,763 Reduced 41.69%
20,650 $4.69 Million
Q4 2019

Feb 04, 2020

BUY
$234.82 - $306.42 $1.02 Million - $1.34 Million
4,360 Added 14.04%
35,413 $10.7 Million
Q3 2019

Nov 06, 2019

BUY
$237.69 - $310.48 $492,969 - $643,935
2,074 Added 7.16%
31,053 $7.46 Million
Q3 2019

Oct 28, 2019

SELL
$237.69 - $310.48 $93,887 - $122,639
-395 Reduced 1.34%
28,979 $6.96 Million
Q2 2019

Aug 15, 2019

BUY
$236.25 - $293.76 $1.01 Million - $1.25 Million
4,258 Added 16.95%
29,374 $0
Q1 2019

May 08, 2019

BUY
$248.42 - $317.42 $3.68 Million - $4.7 Million
14,819 Added 143.92%
25,116 $0
Q4 2018

Feb 05, 2019

SELL
$249.0 - $296.25 $24,651 - $29,328
-99 Reduced 0.95%
10,297 $2.7 Million
Q3 2018

Nov 02, 2018

SELL
$238.27 - $274.12 $246,371 - $283,440
-1,034 Reduced 9.05%
10,396 $0
Q2 2018

Aug 10, 2018

SELL
$220.13 - $245.16 $147,487 - $164,257
-670 Reduced 5.54%
11,430 $0
Q1 2018

May 09, 2018

SELL
$215.63 - $258.19 $3.31 Million - $3.96 Million
-15,333 Reduced 55.89%
12,100 $0
Q4 2017

Feb 22, 2018

BUY
$183.76 - $234.96 $17,457 - $22,321
95 Added 0.35%
27,433 $0
Q3 2017

Nov 07, 2017

BUY
$181.44 - $197.43 $75,841 - $82,525
418 Added 1.55%
27,338 $5.19 Million
Q2 2017

Aug 08, 2017

BUY
N/A
26,920
26,920 $5.07 Million

Others Institutions Holding ELV

About Elevance Health, Inc.


  • Ticker ELV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 240,000,992
  • Market Cap $91.7B
  • Description
  • Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....
More about ELV
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.